Ilya Pharma AB Revenue and Competitors
Estimated Revenue & Valuation
- Ilya Pharma AB's estimated annual revenue is currently $3.4M per year.
- Ilya Pharma AB's estimated revenue per employee is $262,846
Employee Data
- Ilya Pharma AB has 13 Employees.
- Ilya Pharma AB grew their employee count by -7% last year.
Ilya Pharma AB's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | Chair the Board Directors | Reveal Email/Phone |
3 | Clinical Operations Manager | Reveal Email/Phone |
4 | Clinical Operations Manager | Reveal Email/Phone |
5 | Senior Scientist | Reveal Email/Phone |
6 | PHD Student | Reveal Email/Phone |
Ilya Pharma AB Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 221 | 16% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 91 | -10% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 16 | -6% | $114.3M | N/A |
#8 | $7.2M | 28 | -7% | N/A | N/A |
#9 | $13.7M | 51 | -9% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Ilya Pharma AB?
Ilya Pharma is a clinical stage SME developing next generation immunotherapies to treat wounds in skin and mucosa.
keywords:N/AN/A
Total Funding
13
Number of Employees
$3.4M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ilya Pharma AB News
2022-04-13 - Ilya Pharma Acquires Nordic Bioanalysis
Following the acquisition, Nordic Bioanalysis AB will continue to run at arm's length as an independent commercial entity. The aim is to expand...
2022-03-22 - Global Roundup: Oxford Hub Expanding into "Ideal ...
Hansa Biopharma AB Sweden-based Hana reached a reimbursement ... Ilya Pharma Sweden-based Ilya closed a financing round of 8.5 million...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.6M | 13 | -13% | N/A |
#2 | $0.8M | 13 | -50% | N/A |
#3 | N/A | 13 | 30% | $7M |
#4 | $1.3M | 15 | N/A | N/A |
#5 | $1.8M | 15 | 25% | N/A |